Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Simplify Health Care ETF (PINK)

Simplify Health Care ETF (PINK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Simplify ETFs
  • Assets Under Management 117,627,800
  • Shares Outstanding, K 4,025
  • 60-Month Beta 0.70
Trade PINK with:
  • Price/Earnings ttm 0.04
  • Annual Dividend & Yield 0.27 (0.92%)
  • Most Recent Dividend 0.030 on 03/25/24
  • Management Fee 0.50%
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 30.29% ( +30.29%)
  • Historical Volatility 13.34%
  • IV Percentile 99%
  • IV Rank 100.00%
  • IV High 30.29% on 04/22/24
  • IV Low 0.08% on 09/06/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 32
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 116
  • Open Int (30-Day) 149

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.58 +1.71%
on 04/19/24
31.05 -6.36%
on 03/28/24
-1.07 (-3.55%)
since 03/25/24
3-Month
28.18 +3.16%
on 01/26/24
31.05 -6.36%
on 03/28/24
+0.94 (+3.36%)
since 01/25/24
52-Week
23.51 +23.65%
on 10/27/23
31.05 -6.36%
on 03/28/24
+3.21 (+12.41%)
since 04/25/23

Most Recent Stories

More News
ETFs in Focus on Sanofi and Regeneron's COPD Drug Data

Shares of drugmakers Sanofi and Regeneron surged more than 6% on Mar 23 on COPD drug data.

REGN : 890.68 (-1.75%)
SNY : 49.36 (+5.90%)
IBB : 125.67 (-1.64%)
BBH : 154.77 (-1.63%)
IBBQ : 20.52 (-1.25%)
PINK : 29.07 (-0.48%)
ETFs to Buy on UnitedHealth's Q2 Earnings Beat

UnitedHealth reported better-than-expected second-quarter 2022 results, breezing past the Zacks Consensus Estimate for both earnings and revenues. The company lifted its full-year earnings guidance for...

UNH : 493.86 (+1.35%)
XLV : 139.92 (-0.67%)
IYH : 58.68 (-0.69%)
IHF : 52.10 (-0.28%)
IEHS : 41.40 (-0.02%)
PINK : 29.07 (-0.48%)
Simplify Announces Launch of the Simplify Macro Strategy ETF (FIG) Led by Hedge Fund Veteran Michael Green

Simplify Asset Management (“Simplify”) , an innovative provider of Exchange Traded Funds (“ETFs”) designed to solve today’s most pressing portfolio construction challenges, is today launching...

FIG.TO : 9.06 (-0.22%)
CTA : 27.58 (+1.62%)
SPD : 30.19 (-0.43%)
PFIX : 55.30 (+3.40%)
PINK : 29.07 (-0.48%)
FIG : 22.90 (-0.60%)
Healthcare ETFs to Gain on UnitedHealth's Solid Q1 Earnings

UnitedHealth reported better-than-expected first-quarter 2020 results, breezing past the Zacks Consensus Estimate for both earnings and revenues. The company lifted its full-year earnings guidance.

XLV : 139.92 (-0.67%)
IYH : 58.68 (-0.69%)
IHF : 52.10 (-0.28%)
IEHS : 41.40 (-0.02%)
PINK : 29.07 (-0.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The Simplify Health Care ETF seeks long term capital appreciation by providing investors with multi-cap exposure to groundbreaking and innovative companies in biotech, medtech, gene therapy, and other fast growing health care related sectors.

See More

Key Turning Points

3rd Resistance Point 29.63
2nd Resistance Point 29.40
1st Resistance Point 29.23
Last Price 29.07
1st Support Level 28.84
2nd Support Level 28.61
3rd Support Level 28.44

See More

52-Week High 31.05
Last Price 29.07
Fibonacci 61.8% 28.17
Fibonacci 50% 27.28
Fibonacci 38.2% 26.39
52-Week Low 23.51

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar